EVALUATION OF MOLECULAR MONITORING AND RESPONSE MILESTONE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TO TYROSINE KINASE INHIBITORS IN MIDDLE EUPHRATES OF IRAQ

Evaluation of molecular monitoring and response milestone of patients with chronic myeloid leukemia to tyrosine kinase inhibitors in Middle Euphrates of Iraq

Background: In the last decade, tremendous changes occurred in the treatment and follow-up of the patients with chronic myeloid leukemia (CML), with continuous update in the close molecular monitoring of treatment for the presence of minimal residual disease.Objectives: The objective of this study was to evaluate read more the molecular monitoring

read more